Canopy Growth Reports Revenues of $110.4 Million, Net Loss of $128.3 Million For Q1 2021

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) this morning reported its first quarter financials for the period ended June 30, 2020. The company reported net revenues of $110.4 million, while posting a net loss of $128.3 million for the quarter, a marginal increase over revenues of $107 million in the fourth quarter of fiscal year 2020.

Thr bright side from this quarters financials, is that the company managed to post a positive gross margin, even if it only came in at 6%. In dollar terms, gross margin amounted to $6.5 million. In terms of revenue segments, on a year over year basis Canopy’s revenues from the recreational market fell by 11%, from $49.5 million to $44.2 million. Comparatively, global medical revenue grew by 54% to $34.1 million, from $22.2 million. All other revenue also grew on a quarter over quarter basis, from $18.8 million to $32.1 million. Comparatively, sales were up 22% from $90.5 million year over year.

The operation itself however has yet to prove its sustainable, with Canopy recognizing $178.9 million in total operating expenses for the quarter, of which $135.4 million was classified as selling, general and administrative expenses. Asset impairments and restructuring costs came in at $12.8 million for the quarter.

The loss for the quarter however was reduced as a result of “other income” of $48.2 million along with an income tax recovery of $3.0 million, bringing the net loss for the quarter to $128.3 million, despite the massive operating expenses exhibited by the firm.

Looking to the balance sheet, the firm saw its cash and cash equivalents deplete to $975.9 million from $1,303.2 million in the previous quarter. However, this was largely offset by short-term investments climbing to $1,060.9 million from $673.3 million, with the overall boost in the firms cash position a result of the $245 million received by the company from Constellation Brands (NYSE: STZ) exercising certain warrants during the quarter. Accounts receivable declined to $72.6 million from that of $90.2 million, while inventory remained relatively flat at $389.8 million, down marginally from $391.1 million in the prior quarter. Total current assets is currently pegged at $2,613.9 million.

Accounts payable meanwhile fell from $123.4 million to that of $89.4 million, while other accrued expenses climbed to $83.0 million from $65.0 million. Other liabilities fell significantly, from $420.6 million to $319.7 million. Total current liabilities came in at $319.7 million.

Finally, the company also reported that its free cash flow for the quarter amounted to -$180.1 million, an improvement from -$379.1 million in the year ago period.

The company has yet to file full financials statements with Sedar as of the time of writing.

Canopy Growth Corp last traded at $16.63 on the NYSE.


Information for this briefing was found via Sedar and Canopy Growth. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

Stifel-GMP: Canopy Growth CEO’s Legacy is “Poor Execution, Misallocated Capital, and Mismanaged Expectations.”

Earlier this month, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their fiscal second-quarter 2022...

Sunday, November 21, 2021, 12:03:00 PM

Canopy Growth: Analysts Anticipate Q1 Revenues Of $149 Million

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) announced that they will be reporting their fiscal...

Tuesday, August 3, 2021, 03:28:00 PM

Canopy Growth Sells BioSteel Assets For $30.4 Million

Canopy Growth (TSX: WEED) has unsurprisingly taken a loss on its investment into BioSteel, with...

Friday, December 1, 2023, 09:09:45 AM

Canopy Growth Posts 9% Revenue Decline, Continued Net Losses In Q2 FY2025

Canopy Growth Corporation (TSX: WEED) released its Q2 FY2025 results today, revealing a mixed financial...

Friday, November 8, 2024, 07:48:52 AM

Canopy Growth Acquires 72% Stake in Biosteel Sports Nutrition

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) announced today that it had entered into an...

Wednesday, October 2, 2019, 09:12:11 AM